Livent (NASDAQ:LTHM) released its quarterly earnings data on Monday. The company reported $0.23 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.23, Morningstar.com reports. Livent updated its FY 2019 guidance to $0.92-0.98 EPS and its Q1 2019 guidance to $0.11-0.14 EPS.
Shares of LTHM opened at $13.12 on Tuesday. Livent has a twelve month low of $12.10 and a twelve month high of $19.90.
Several institutional investors and hedge funds have recently made changes to their positions in LTHM. Athena Capital Advisors LLC bought a new stake in shares of Livent during the fourth quarter valued at about $28,000. PNC Financial Services Group Inc. bought a new position in shares of Livent in the fourth quarter worth approximately $31,000. Glassman Wealth Services bought a new position in shares of Livent in the fourth quarter worth approximately $33,000. Advisor Group Inc. bought a new position in shares of Livent in the fourth quarter worth approximately $115,000. Finally, Birchview Capital LP bought a new position in shares of Livent in the fourth quarter worth approximately $138,000.
Several equities research analysts have commented on the stock. Buckingham Research assumed coverage on shares of Livent in a report on Wednesday, November 14th. They set a “neutral” rating and a $18.00 price objective on the stock. They noted that the move was a valuation call. Credit Suisse Group started coverage on shares of Livent in a report on Monday, November 5th. They set an “outperform” rating and a $20.00 price objective on the stock. Goldman Sachs Group started coverage on Livent in a research report on Monday, November 5th. They set a “buy” rating and a $22.00 price target on the stock. Nomura cut Livent from a “buy” rating to a “neutral” rating in a research report on Tuesday, January 15th. Finally, Loop Capital started coverage on Livent in a research report on Friday, November 9th. They set a “buy” rating and a $22.00 price target on the stock. Four analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. Livent has a consensus rating of “Buy” and an average target price of $19.85.
Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.
Featured Story: Cost of Debt
Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.